Steven J.  Fishman , MD

Dr. Fishman is a full-time pediatric surgeon. His practice includes the full range of newborn and pediatric surgical care. He has a particular research and clinical interest in vascular anomalies, including hemangiomas and vascular malformations. This field is not well taught or studied in any of the classic disciplines of medicine. He is Co-Director of the multidisciplinary Vascular Anomalies Center at Childrens Hospital Boston. He has a particular focus on developing an understanding and approach to visceral vascular anomalies. Though these anomalies are extremely rare, an international referral practice has facilitated the recognition of patterns in clinical presentation and opportunities for treatment. He has focused on developing evaluation and intervention techniques including innovative operative procedures for the treatment of visceral vascular anomalies. The utility of a modified endorectal pull-through technique for the treatment of colorectal venous malformations has been demonstrated. A surgical technique to eradicate gastrointestinal bleeding in the Blue Rubber Bleb Nevus Syndrome has been developed and proven successful. In addition, the role of dynamic contrast lymphangiography of the thoracic duct has allowed for novel treatments and reconstruction of thoracic duct anomalies. Recognizing the limitations of surgical techniques, he is also focusing on understanding the biologic mechanisms involved in the development and progression of these lesions. He has focused on known angiogenic modulators as well as metalloproteinases, having recently identified the likely importance of high molecular weight matrix metalloproteinases in patients with aggressive vascular anomalies. Dr. Fishman is the principle investigator on a phase I clinical trial which is well under way of a metalloproteinase inhibitor in patients with devastating lesions. Dr. Fishman is the Secretary General of the International Society for the Study of Vascular Anomalies (ISSVA). He participates in the national and international education of specialists from multiple disciplines interested in the field of vascular anomalies as a frequent visiting professor and invited lecturer in various postgraduate symposia. In addition, he advises several patient/family-oriented support groups and frequently participates in their gatherings and clinics. Another area of research and clinical interest is in minimally invasive surgical techniques. As the first pediatric surgeon in Boston to perform minimally invasive procedures in infants and children, he has actively participated in the evolution of these techniques to the pediatric age group. Dr. Fishman is now applying robotic surgical techniques in pediatric procedures and is attempting to define their role. He also introduced the use of botulinum toxin injection in the internal anal sphincter for refractory Hirschsprungs disease and other anal sphincter motility disorders in Boston. In addition, he was one of the first to introduce the non-refluxing continent appendicocecostomy to this country. This has been very useful for the treatment of patients with fecal incontinence and constipation due to colorectal neuromotor abnormalities.

www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=fauza+do%5BAuthor%5D+OR+fauza+d%5BAuthor%5D

www.childrenshospital.org/cfapps/research/data_admin/Site431/mainpageS431P0.html

• Children's Hospital Boston
  300 Longwood Avenue

  Fegan 3

  Boston, MA  02115
  Phone: 617-355-3040
  Fax: 617-730-0752

Other Office Location